Uniphar (LON:UPR) Reaches New 52-Week High - Should You Buy?

Key Points

• Uniphar plc reached a new 52-week high at GBX 350 ($4.71) during trading, having previously closed at GBX 342 ($4.60).
• Wall Street analysts maintain a Moderate Buy rating for Uniphar with an average target price of GBX 375, with one analyst issuing a Buy and another a Hold rating.
• The company has a market cap of £1.08 billion and reported a price-to-earnings ratio of 24.08, indicating strong market presence in the diversified healthcare services sector.

Uniphar plc (LON:UPR - Get Free Report) hit a new 52-week high during mid-day trading on Thursday . The stock traded as high as GBX 350 ($4.71) and last traded at GBX 350 ($4.71), with a volume of 6619 shares trading hands. The stock had previously closed at GBX 342 ($4.60).

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Deutsche Bank Aktiengesellschaft reissued a "hold" rating and set a GBX 375 price target on shares of Uniphar in a research note on Wednesday, July 30th. Shore Capital restated a "buy" rating on shares of Uniphar in a research report on Thursday, May 29th. One investment analyst has rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of GBX 375.

Uniphar Stock Up 3.1%

The company has a debt-to-equity ratio of 119.48, a quick ratio of 0.60 and a current ratio of 0.90. The firm's fifty day simple moving average is GBX 329.57 and its 200 day simple moving average is GBX 275.79. The stock has a market capitalization of £1.09 billion, a price-to-earnings ratio of 24.27 and a beta of 0.75.

Uniphar Company Profile

Headquartered in Dublin, Ireland Uniphar plc is a diversified healthcare services business servicing the requirements of more than 200 multinational pharmaceutical and medical technology manufacturers across three divisions – Commercial & Clinical, Product Access and Supply Chain & Retail. With a workforce of more than 2,000, the Group is active in Ireland, the UK and the Benelux.